Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain metastases from unknown primary tumour: a prospective study.

R Rudà1, M Borgognone, F Benech

  • 1Department of Neuroscience, University of Torino, Italy.

Journal of Neurology
|July 5, 2001
PubMed
Summary

Optimal management for brain metastases from unknown primary tumors remains unclear. Surgery and whole-brain radiotherapy (WBRT) can control brain disease, with survival depending on metastasis number.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prolonged sequential temozolomide in glioblastoma: A systematic review with exploratory quantitative synthesis.

Cancer treatment and research communications·2026
Same author

Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

ESMO open·2023
Same author

An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma: the BMRCC study.

ESMO open·2023
Same author

The role of the neurologist in the diagnosis and treatment of brain metastases and carcinomatous meningitis.

Revue neurologique·2023
Same author

Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.

Journal of neuro-oncology·2022
Same author

Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Area of Science:

  • Neuro-oncology
  • Oncology
  • Neurosurgery

Background:

  • Management of brain metastases from unknown primary tumors lacks clear guidelines due to limited data.
  • Retrospective studies are the primary source of information for this challenging clinical scenario.

Purpose of the Study:

  • To evaluate the efficacy of surgery and/or radiotherapy in patients with brain metastases from an initially undetected primary tumor.
  • To identify prognostic factors influencing survival in this patient population.

Main Methods:

  • Retrospective analysis of 33 patients with biopsy-proven brain metastases from an unknown primary tumor.
  • Treatment modalities included surgery and/or whole-brain radiotherapy (WBRT).
  • Patients were followed with serial CT scans until death.

Related Experiment Videos

Main Results:

  • Median survival was 10 months; 2-year survival was 15%.
  • Single brain metastasis treated with gross total resection and WBRT had a median survival of 13 months.
  • Multiple brain metastases had a poorer prognosis, with median survival of 6-8 months.
  • Neurological improvement was observed in 85% of single metastasis patients post-surgery.
  • The primary tumor was identified in 82% of patients, most commonly lung cancer.
  • Number of brain metastases was the sole significant prognostic factor.

Conclusions:

  • Surgery and/or WBRT can effectively control brain disease in patients with metastases from an unknown primary.
  • The number of brain metastases is a critical factor determining patient survival.
  • Systemic disease may remain clinically silent for extended periods, influencing treatment strategies.